What is a Recombinant DNA technology?

Recombinant DNA technology is a powerful tool used by molecular biology researchers to create hybrid or chimeric DNA to develop pharmaceutical products or study the function and regulation of gene or DNA sequences of interest.

The process involves several key steps:

• The DNA sequence of interest and a self-replicating vector (e.g., plasmid) are cleaved
• The same restriction endonuclease enzyme is used for both
• The DNA fragment is joined to the vector using DNA ligase
• This joining step is known as ligation

The vector is then introduced into a bacterial cell (such as E. coli) or a yeast cell, where its replication and translation machinery are used to replicate plasmids and synthesize the desired proteins. The technology has successfully produced therapeutic products, such as insulin, vaccines, and growth hormones, to treat various human diseases.

However, during transformation, cells may take up different types of plasmids:

• Recombinant plasmids containing the desired DNA insert
• Self-ligated vectors without the insert

Both kinds of transformants will grow on the selective medium. Thus, it’s necessary to screen all the transformants using an appropriate screening technique. The process enables us to obtain clones that are accurately transformed, containing a recombinant plasmid and have the inserted or desired DNA sequence in the right orientation.

Explore this article further to learn about various screening techniques available, why they are crucial for research and development, and advancements in the field.

The basics and importance of screening methods in recombinant DNA technology

The process of cloning uses restriction endonuclease enzymes to cut plasmid and gene inserts to generate ends (sticky or blunt ends) that can be ligated. However, the process of ligation can lead to the formation of three kinds of products:

• Self-ligated vector (vector without gene) - In cloning experiments, self-ligation may occur without the insertion of the desired fragment, leading to the formation of empty vectors. This makes it difficult to isolate the desired recombinant clones and reduces cloning efficiency.
• Vector with the gene or DNA sequence of interest (recombinants) - Recombinants enable the production of multiple copies of the gene or sequence for further research, manipulation or cell engineering.
• Gene-gene ligated product – A result of the joining of two different genes, this can lead to the creation of chimeric genes that may exhibit desired or enhanced biological activities.

When these products are introduced into a bacterial or fungal host and plated on appropriate agar media, a mixture of clones, each containing all three products, is formed. Thus, in this regard, screening approaches are needed to identify the correct clone carrying a vector containing the gene of interest. They differentiate recombinants from non-recombinants.

Screening genomic and cDNA libraries containing thousands of distinct clones and DNA fragments helps obtain the desired clone in a single shot. This saves a sizeable amount of time, effort, resources, and money spent on performing the same experiment repeatedly.

Overall, the success of a cloning experiment depends on the application of a screening approach.

What is clone screening vs clone selection?

Commonly used screening methods in recombinant DNA technology

Antibiotic-based screening approach

Image of Antibiotic-based screening

In this method, recombinants are distinguished by the absence of the gene function encoded by the vector. For instance, if the pBR322 plasmid vector carries two antibiotic resistance genes (ampicillin and tetracycline), it can grow on a medium containing either antibiotic.

However, a fault or mutation in any one of the antibiotic resistance genes, due to the insertion of the gene of interest, makes them sensitive to that antibiotic. For example, if the gene is inserted between the tetracycline gene, the recombinants will be sensitive to tetracycline but will be able to grow on ampicillin.

The screening process involves replica plating, which allows comparison across conditions:

• Colonies are first grown on an ampicillin-containing master plate
• A nitrocellulose membrane is pressed onto the plate to copy the colony pattern
• The membrane is transferred to a plate containing both ampicillin and tetracycline
• Only non-recombinant colonies survive on the second plate

By comparing the master and replica plates, colonies present on the master but absent on the replica are identified as recombinants. This method enables accurate identification of recombinant clones by combining antibiotic selection with functional screening.

Chromogenic screening method (Blue-White Screening)

Image of Chromogenic screening method

It’s one of the oldest and most commonly used techniques for recombinant screening, distinguishing recombinant clones from non-recombinants based on color differences between colonies. It’s commonly known as blue-white screening.

The technique utilizes a β-galactosidase enzyme, encoded by the lacZ gene in E. coli, that hydrolyzes X-Gal (a lactose analog) into 5′-dibromo-4,4′-dichloro-indigo (an insoluble, deep-blue pigment), forming deep-blue colonies.

The system is based on α-complementation:

• The host cells are lacZ mutants and cannot produce a functional enzyme on their own
• The plasmid vector encodes only part of the β-galactosidase enzyme
• A functional enzyme is produced only when both components complement each other

During the process, the gene of interest is inserted into the multiple cloning site (MCS) within the lacZ gene. After ligation, the vector is transformed into E. coli and grown on agar containing an antibiotic, X-gal, and IPTG to enable selection and color development.

Colonies are then distinguished visually:

• White colonies: recombinant (disrupted lacZ, non-functional enzyme)
• Blue colonies: non-recombinant (functional β-galactosidase)

Colony PCR

Image of colony PCR

After the blue-white screening, it’s another commonly used screening technique for recombinants. In this method, all the bacterial or fungal colonies from the master plate are pooled in a multi-well plate. The cells are lysed and subjected to PCR along with a set of target DNA-specific primers.

Subsequently, individual colonies from the master plate, part of the positive pool, undergo PCR with the same set of primers. The technique will produce a product of known size only when the insert is present. In its absence, a product of a different size will be observed on the agarose gel. The method offers more accurate and rapid detection of recombinant target clones and also the orientation of the insert. However, it is only effective for products under 1 KB.

Nucleic acid hybridization technique

Image of the acid hybridization technique

The technique utilizes the probe's binding efficiency to the target sequence. The greater the similarity between the probe and target sequences, the higher the homology percentage. For example, if the sequence and probe come from the same organism, they will be 100% homologous. However, the percentage decreases in case the sequence is from a related but not the same organism. In the process, the DNA/RNA probes are labeled with radioactive (less commonly used) or non-radioactive molecules, such as enzymes, and detected by fluorescence or a color change resulting from reaction with the substrate.

Screening with restriction enzymes

Restriction enzyme screening verifies the presence, size, and orientation of a DNA insert within a plasmid. After transformation, plasmid DNA is first isolated from selected colonies. The plasmid is then digested with one or more restriction enzymes that cut at known sites within the vector and/or insert. The resulting DNA fragments are separated using gel electrophoresis and compared to expected fragment sizes. This method provides a straightforward way to validate recombinant constructs before sequencing.

Sanger sequencing Screening

Sanger sequencing is regarded as the gold standard for validating recombinant DNA constructs because it precisely determines the nucleotide sequence of the inserted DNA. After initial screening (such as blue-white screening or PCR), plasmid DNA from candidate clones is sequenced using primers that flank the insertion site. The obtained sequence is then compared to the expected reference to verify accuracy. Unlike other screening methods, Sanger sequencing offers definitive validation of the construct.

What are the challenges of recombinant DNA screening?

• False positives/negatives
  • Blue-white screening ambiguity with small inserts
• Primer dependency
  • Colony PCR requires high specificity
• Time and cost constraints
  • Sequencing is accurate but expensive
• Scalability limitations
  • Manual workflows limit throughput
• Host system dependency
  • Some methods require engineered strains

Advancements in screening methods

Blue-white screening (like pBlueScript) has been used for over 25 years but requires specific bacteria with α-subunit gene deletions and X-gal. During cloning, results can be ambiguous, especially with small inserts. Colony PCR also demands highly accurate primers. These limitations call for advanced methods that simplify screening, are effective, and save time.

For example, researchers developed a pRedScript technique (a modified version of pBlueScript) that allows screening recombinants using red (non-recombinant) or white (recombinant) color. However, the method does not require any specialized instruments or engineered bacteria, unlike the pBlueScript technique. Similarly, this study describes an ultra-high-efficiency colony PCR method that can be used with different host strains (unlike traditional colony PCR, which is restricted to E. coli strains), is rapid and can be performed with just a few pieces of equipment.

Thus, researchers are working to improve the traditional technique to develop a robust, time-saving, and inexpensive screening approach for large-scale applications.

Conclusion

Specific recombinant clones can now be isolated and characterized using cDNA and genomic libraries. We now better understand the genetic material of prokaryotic and eukaryotic organisms, including their localization within cells, structure, organization, regulation, and gene expression.

Effective gene isolation, identification, and cloning enable recombinant protein expression for research, agriculture, and medicine. Screening is essential for efficiently finding the right clones, saving time and resources.

While traditional methods like blue-white screening and colony PCR are used to identify clones, scientists are developing advanced high-throughput methods or modifying traditional techniques to create systems that speed up screening, reduce the need for specialized equipment, and make screening more cost-effective, faster, and accessible.